Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes

Completed

Conditions studied: Healthy

In brief

The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.

Key facts

Study ID

NCT00413751

Run by

Walter Reed Army Medical Center

People needed

20

Last updated by the study team

2006-12-20

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult active duty personnel between 18 and 50 years of age with best corrected visual acuity of 20/20 or better.

You may not qualify if…

• Patients not meeting above stated age criteria
• Females that are pregnant or lactating (non pregnant females of childbearing potential will have pregnancy test prior to participating in study)
• History of serious ocular, neurological, cardiovascular disease
• History of severe systemic disease
• History of arrhythmias or high blood pressure
• Patients currently taking any type of ocular or systemic medications except multivitamins.
• Patients with abnormal pupil shape, Addie's pupil, anisocoria, or abnormal pupil defect.

Where it is running

• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.